Home
/
ENvue Medical, Inc.
/
Financials
/
Quarterly
ENvue Medical, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ENvue Medical, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2019
Sep 30, 2019
$101.0K
Nov 19, 2019
Q2
2019
Jun 30, 2019
$263.0K
Aug 14, 2019
Q1
2019
Mar 31, 2019
$79.0K
May 20, 2019
Q3
2019
Sep 30, 2018
$54.0K
Nov 19, 2019
Q2
2019
Jun 30, 2018
$132.0K
Aug 14, 2019
Q1
2019
Mar 31, 2018
$77.0K
May 20, 2019
Q3
2018
Sep 30, 2017
$65.0K
Nov 14, 2018
Q2
2018
Jun 30, 2017
$52.0K
Aug 14, 2018
Q1
2018
Mar 31, 2017
$52.0K
May 15, 2018
Q3
2017
Sep 30, 2016
$61.0K
Nov 14, 2017
Q2
2017
Jun 30, 2016
$62.0K
Aug 14, 2017
Q1
2017
Mar 31, 2016
$57.0K
Jul 26, 2017
Q3
2016
Sep 30, 2015
$40.0K
Nov 14, 2016
Q2
2016
Jun 30, 2015
$39.0K
Aug 15, 2016
Q1
2016
Mar 31, 2015
$29.0K
May 16, 2016
Q3
2015
Sep 30, 2014
$25.0K
Nov 16, 2015
Q2
2015
Jun 30, 2014
$64.0K
Aug 14, 2015
Q1
2015
Mar 31, 2014
($62.0K)
Jun 10, 2015
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$722.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
$494.0K
Aug 19, 2025
Q1
2025
Mar 31, 2025
$1.03M
May 20, 2025
Q3
2025
Sep 30, 2024
$376.0K
Nov 14, 2025
Q2
2025
Jun 30, 2024
$817.0K
Aug 19, 2025
Q1
2025
Mar 31, 2024
$921.0K
May 20, 2025
Q3
2024
Sep 30, 2023
$458.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$294.0K
Aug 14, 2024
Q1
2024
Mar 31, 2023
$354.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$97.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$485.0K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$272.0K
May 15, 2023
Q3
2022
Sep 30, 2021
$499.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$318.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$103.0K
May 16, 2022
Q3
2021
Sep 30, 2020
$150.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$269.0K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$114.0K
May 24, 2021
Q3
2020
Sep 30, 2019
$101.0K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$263.0K
Aug 24, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$510.0K
Nov 14, 2025
Q2
2025
Jun 30, 2025
($3.97M)
Aug 19, 2025
Q1
2025
Mar 31, 2025
($2.50M)
May 20, 2025
Q3
2025
Sep 30, 2024
($998.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($688.0K)
Aug 19, 2025
Q1
2025
Mar 31, 2024
($588.0K)
May 20, 2025
Q3
2024
Sep 30, 2023
($727.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.07M)
Aug 14, 2024
Q2
2023
May 22, 2023
$500.0K
Aug 11, 2023
Q3
2023
May 22, 2023
$500.0K
Nov 13, 2023
Q1
2024
Mar 31, 2023
($1.10M)
May 15, 2024
Q3
2023
Sep 30, 2022
($955.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($1.30M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($1.13M)
May 15, 2023
Q3
2022
Sep 30, 2021
($6.68M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($216.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($4.92M)
May 16, 2022
Q3
2021
Sep 30, 2020
($922.0K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.48M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($921.0K)
May 24, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($2.25M)
Nov 14, 2025
Q2
2025
Jun 30, 2025
($3.98M)
Aug 19, 2025
Q1
2025
Mar 31, 2025
($1.85M)
May 20, 2025
Q3
2025
Sep 30, 2024
($970.0K)
Nov 14, 2025
Q2
2025
Jun 30, 2024
($674.0K)
Aug 19, 2025
Q1
2025
Mar 31, 2024
($568.0K)
May 20, 2025
Q3
2024
Sep 30, 2023
($670.0K)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($1.01M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.06M)
May 15, 2024
Q3
2023
Sep 30, 2022
($924.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($1.27M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($1.11M)
May 15, 2023
Q3
2022
Sep 30, 2021
($868.0K)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($991.0K)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($1.31M)
May 16, 2022
Q3
2021
Sep 30, 2020
($804.0K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($1.47M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($907.0K)
May 24, 2021
Q3
2020
Sep 30, 2019
($793.0K)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($896.0K)
Aug 24, 2020